Mireia Garriga-Canut

Title: Mireia Garriga-Canut: Innovator in Gene Therapy

Introduction

Mireia Garriga-Canut is a prominent inventor based in Barcelona, Spain. She has made significant contributions to the field of gene therapy through her innovative work on zinc finger peptides. With a total of 2 patents, her research focuses on the modulation of gene expression and the targeting of mutant genes.

Latest Patents

Garriga-Canut's latest patents include groundbreaking work on zinc finger peptides that possess at least four zinc finger domains. These peptides can be fused to effector domains, allowing for the modulation of gene expression. The invention is particularly useful for targeting trinucleotide-repeat sequences in mutant genes, which has potential applications in gene therapy. Additionally, her patents disclose methods for constructing poly-zinc finger peptides with arrays of at least eight zinc finger domains, along with frameworks for selecting zinc finger peptides from libraries.

Career Highlights

Throughout her career, Garriga-Canut has worked with esteemed organizations such as the Fundació Centre de Regulació Genòmica and the Fundació Privada Centre de Regulació Genòmica. Her work in these institutions has furthered the understanding and application of genetic regulation.

Collaborations

One of her notable collaborators is Mark Isalan, with whom she has worked on various projects related to gene therapy and peptide research.

Conclusion

Mireia Garriga-Canut is a trailblazer in the field of gene therapy, with her innovative patents paving the way for future advancements in genetic research. Her contributions continue to impact the scientific community and hold promise for therapeutic applications.